Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,768,884 papers from all fields of science
Search
Sign In
Create Free Account
Methoxy polyethylene glycol-epoetin beta
Known as:
Pegzerepoetin Alfa
, methoxypolyethylene glycol epoetin beta
, epoetin beta pegol
Expand
A substance that is being studied in the treatment of anemia in patients who are receiving chemotherapy. It is a form of erythropoietin (a substance…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
13 relations
0.3 ML Methoxy polyethylene glycol-epoetin beta 0.167 MG/ML Prefilled Syringe
0.3 ML Methoxy polyethylene glycol-epoetin beta 0.25 MG/ML Prefilled Syringe
0.3 ML Methoxy polyethylene glycol-epoetin beta 0.333 MG/ML Prefilled Syringe
0.3 ML Methoxy polyethylene glycol-epoetin beta 0.5 MG/ML Prefilled Syringe
Expand
Narrower (2)
Mircera
Ro 50-3821
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Methoxy Polyethylene Glycol-Epoetin beta
Definitions
2020
Corpus ID: 45253164
2015
2015
[Comparison of benefits to non-dialysis CKD patients between darbepoetin alpha and epoetin beta pegol].
C. Ito
,
T. Akimoto
,
+8 authors
D. Nagata
Nihon Jinzo Gakkai shi
2015
Corpus ID: 21013919
BACKGROUND Erythropoiesis-stimulating agents (ESAs) are the mainstay of treatment for renal anemia in chronic kidney disease (CKD…
Expand
2014
2014
Variabilidad en los valores de hemoglobina con la administración mensual de metoxipolietilenglicolepoetina beta a pacientes en hemodiálisis con anemia
Natalie Leonor Córdova-Villafuerte
2014
Corpus ID: 79415298
intrOductiOn. Anemia, a common complication in patients with chronic renal disease, is increased in patients on hemodialysis…
Expand
Review
2014
Review
2014
[Erythropoiesis stimulating agents in clinical practice].
L. Niemczyk
,
M. Debowska
Wiadomosci lekarskie
2014
Corpus ID: 31415582
Anemia is one of the most common problems of patients with advanced chronic kidney disease (CKD). Its main causes in this…
Expand
2013
2013
血液透析患者における epoetin beta pegol 使用時のヘモグロビン月内変動の検討
昭英 井口
,
肇 山崎
,
朋之 伊藤
,
敬子 佐伯
,
一衛 成田
2013
Corpus ID: 196218254
2013
2013
Leukocytoclastic Vasulitis Induced by Methoxy Polyethylene Glycol-Epoetin Beta.
Sang Yoon Lee
,
J. Go
,
S. Kim
,
Hyun Ok Son
,
H. Cho
2013
Corpus ID: 99487333
2012
2012
Utilización de eritropoyetina beta pegilada en enfermedad renal crónica en estadio 3, 4 o 5 no-D
Núria Padullés-Zamora
,
D. Comas-Sugrañes
,
M. Pineda-Yuste
,
R. Jódar-Masanés
,
A. Martínez-Castelao
2012
Corpus ID: 70370451
Background: Methoxy polyethylene glycol-epoetin beta (PEG-EPO) is indicated for the treatment of anaemia due to chronic kidney…
Expand
2012
2012
Modern Management of Post-Transplant Anaemia - Focus on Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) and IV Iron Therapies: 1276
H. Penny
,
C. Breen
,
S. Hall
,
S. Frame
,
D. Goldsmith
2012
Corpus ID: 75827785
2008
2008
Methoxy polyethylene glycol-epoetin beta: new drug. Pegylated epoetin beta: risk of cardiovascular disorders.
Prescrire international
2008
Corpus ID: 39653603
No tangible benefit, but a risk of cardiovascular adverse effects due to haemogloblin levels that are frequently too high…
Expand
1999
1999
PRELIMINARY STUDY ON COLLAGENASE MODIFIED WITH METHOXYPOLYETHYLENE GLYCOL5000
Jiang Jiang
1999
Corpus ID: 87423981
In order to overcome the immunogenicity of collagenase,the enzyme was modified with monomethoxypolyethylene glycol 5000 (mPEG…
Expand